期刊文献+

急性冠状动脉综合征患者血清胱抑素C、白细胞介素-6的变化 被引量:2

Levels of serum Cystatin C and IL-6 and its clinical significance in patients with acute coronary syndrome
原文传递
导出
摘要 目的:分析急性冠状动脉(冠脉)综合征(ACS)患者血清胱抑素C(CysC)和白细胞介素6(IL-6)水平变化及临床意义。方法:选择2010-08-2011-12我院住院患者102例,分为急性心肌梗死(AMI)组30例、不稳定型心绞痛(UAP)组45例、稳定型心绞痛(SAP)组27例;另选取77例非冠心病(CHD)住院患者为非CHD组。分别测定各组血清CysC与IL-6水平,组间进行两两比较。结果:UAP组血清CysC水平明显高于SAP组及非CHD组;AMI组血清CysC水平较UAP及SAP组低,与非CHD组比较差异无统计学意义。IL-6水平分别为:AMI组>UAP组>SAP组>非CHD组。结论:CysC与IL-6可能与ACS的发生发展有关,早期联合检测CysC与IL-6对预测ACS的发生和发展有一定指导意义。 Objective:To study the change of serum Cystatin C (CysC) and IL-6 levels and its clinical signifi- cance in patients with acute coronary syndrome (ACS). Method: One hundred and two patients with CHD from August 2010 to December 2011 were selected and divided into acute myocardial infarction (AMI) group, unstable angina (UAP) group and stable angina (SAP) group. Seventy-seven patients without CHD were selected in non- (THD group. The level of CysC and IL-6 were detected. Result:The level of CysC in UAP group was higher than that in non-CHD group and SAP group (P〈0.05). The level of CysC in AMI group was lower than that in UAP group and SAP group (P〈0.05), and there was no significant difference between in non-CHD group and AMI group (P〈0.05). The levels of IL-6 from high to low order were AMi group, UAP group, SAP group and non- CHD group. Conclusion:The expression of CysC and IL-6 may play a key role in the occurrence of ACS. Detecting CysC and IL-6 levels have a certain guiding significance in prediction of ACS occurrence.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2012年第12期938-940,共3页 Journal of Clinical Cardiology
关键词 急性冠状动脉综合征 胱抑素C IL-6 acute coronary syndrome Cystatin C interlukin-6
  • 相关文献

参考文献13

二级参考文献126

  • 1章毅,王永志.根据血清胱抑素C浓度推测肾小球滤过率的临床应用[J].中国血液净化,2004,3(12):655-656. 被引量:52
  • 2李海霞,张春丽,徐国宾,王学晶,李淑葵,李志艳,张旭初,夏铁安.健康人群血清半胱氨酸蛋白酶抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究[J].中华检验医学杂志,2006,29(11):970-974. 被引量:179
  • 3董巧玲,刘俊.急性心肌梗死患者血清Cystatin C的变化[J].中国心血管病研究,2007,5(1):27-29. 被引量:19
  • 4Libby P. Inflammation in atherosclerosis [J]. Nature, 2002, 420: 868- 874.
  • 5Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways [J].Physiol IRev, 2006, 86:515-581.
  • 6Cohen S. Cytokine: more than a new word, a new concept proposed by Stanley Cohen thirty years ago[J].Cytokine, 2004, 28: 242-247.
  • 7Hajra L, Evans AI, Chen M, et al. The NF-KB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation [J]. Proc Nail Acad Sci USA, 2000, 97: 9052-9057.
  • 8Ricci R, Sumara G, Sumara I, et al. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis [J]. Science, 2004, 306: 1558-1561.
  • 9Mallat Z, Gojova A, Marchiol-Fournigault C, et al. Inhibition of trans- forming growth factor-beta signaling accelerates athemsclemsis and induces an unstable plaque phenotype in mice[J].Circ Res, 2001, 89: 930-934.
  • 10Ameziane N, Beillat T, Verpillat P, et al. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events [J]. Artefioscler Thromb Vasc Biol, 2003, 23: e61-e64.

共引文献68

同被引文献21

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部